Abstract:
A vehicle suspension assembly includes a control rod pivotally connected between a vehicle frame and an axle. The control rod controls longitudinal and vertical movement of the axle. A spring member is pivotally connected to the frame and fixed to the axle. Air spring assemblies are mounted between the axle and frame. The rigidly mounted spring member exerts torsion forces on the axle to counter roll forces and the air spring assemblies provide favorable ride characteristics adaptable to various trailer load conditions.
Abstract:
This invention features permeability enhancer molecules, and methods, to increase membrane permeability of various molecules, such as nucleic acids, polynucleotides, oligonucleotides, enzymatic nucleic acid molecules, antisense nucleic acid molecules, 2-5A antisense chimeras, triplex forming oligonucleotides, decoy RNAS, dsRNAs, siRNAs, aptamers, or antisense nucleic acids containing nucleic acid cleaving chemical groups, peptides, polypeptides, proteins, carbohydrates, steroids, metals and small molecules, thereby facilitating cellular uptake of such molecules.
Abstract:
Compounds of the general structure D-L-B-(AA), for example (A), that are useful for treating Mac-1 or LFA-1-mediated disorders such as inflammatory disorders, allergies, and autoimmune diseases are provided.
Abstract:
Benzodiazepine derivatives represented by the structure below are disclosed that act as potent inhibitors of ras farnesyl:protein transferase. Pharmaceutical compositions containing these benzodiazepines are provided for treatment of diseases foe which inhibition of the ras farnesyl:protein transferase as indicated. ##STR1##
Abstract:
Benzodiazepine derivatives are disclosed that act as potent inhibitors of ras farnesyl:protein transferase. Pharmaceutical compositions containing these benzodiazepines are provided for treatment of diseases for which inhibition of the ras farnesyl:protein transferase is indicated. Also disclosed are benzazepines of the following general formula (II) having similar utility as the aforementioned benzodiazepines: ##STR1##
Abstract:
A re-useable partitioning seal used storage containers creates a virtually airtight chambers, to preserve products therein. A disc or differently shaped layer, with flat top and bottom surfaces, is configured to fit against the interior surface of a storage container. A thin, flexible perimeter forming a gasket around the layer, and a handle attached to the layer without fissure or cavity, thereby providing and a single piece, inexpensive re-useable partitioning seal.
Abstract:
In accordance with one aspect of an exemplary embodiment, a dryer for removing hydrocarbons and/or moisture from metal chips is provided. The dryer has a chamber including a top portion and a base portion. The top portion is comprised of a material having a higher emissivity than the material forming the base portion. A burner is provided which introduces heated gas into the top portion. A device for transporting the metal chips is provided in the base portion. The device receives the metal chips at an inlet and transporting the metal chips to an outlet.
Abstract:
Slurry walls and methods of using those slurry walls to seal unlined solar ponds are provided. The slurry walls are formed from a mixture comprising clay and cement in water. A trench is keyed into the dike surrounding the solar pond, down to a geotechnically predetermined level. The slurry is deposited into the trench and allowed to harden, after which it is covered with a membrane or other covering. The inventive slurry walls reduce, and preferably prevent, leakage of water from the solar pond.
Abstract:
Compounds of the disclosure provide compositions, which are effective for prophylaxis and treatment of diseases or disorders, such as cell-proliferation, angiogenesis, or apoptosis mediated diseases. The disclosure encompasses compounds, analogs, prodrugs, metabolites, and pharmaceutically acceptable salts thereof, pharmaceutical compositions, and methods for prophylaxis and treatment of diseases and other maladies or conditions involving cancer, tumors, and like conditions. The disclosure also provides therapeutic methods including the administration of an effective amount of a compound of the disclosure.
Abstract:
This invention features permeability enhancer molecules, and methods, to increase membrane permeability of various molecules, such as nucleic acids, polynucleotides, oligonucleotides, enzymatic nucleic acid molecules, antisense nucleic acid molecules, 2-5A antisense chimeras, triplex forming oligonucleotides, decoy RNAs, dsRNAs, siRNAs, aptamers, or antisense nucleic acids containing nucleic acid cleaving chemical groups, peptides, polypeptides, proteins, carbohydrates, steroids, metals and small molecules, thereby facilitating cellular uptake of such molecules.